Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administration-Reference-Cited by-同舟云学术

Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administration

Published:2015-07 Issue: Volume:57 Page:73-83
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Kwak Jin Hee,Zhang Yulong,Park Juyoung,Chen Eric^ORCID,Shen Jia,Chawan Chirag,Tanjaya Justine,Lee Soonchul,Zhang Xinli,Wu Benjamin M.,Ting Kang,Soo Chia

Funder

National Aeronautics and Space Administration

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference54 articles.

1. Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide;Heinemann;Geriatrics,2000

2. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study;Berry;Osteoporos Int,2010

3. Understanding the burden of osteoporosis and use of the World Health Organization FRAX;Shuler;Orthopedics,2012

4. National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist;Watts;J Clin Densitom,2008

5. Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation;Czerwinski;Ortop Traumatol Rehabil,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neural epidermal growth factor-like 1 protein (Nell-1) alleviates periodontal tissue destruction in periodontitis by regulating the ratio of M2/M1 macrophage phenotypes;International Immunopharmacology;2024-08

2. Nel-like Molecule Type 1 Combined with Gold Nanoparticles Modulates Macrophage Polarization, Osteoclastogenesis, and Oral Microbiota in Periodontitis;ACS Applied Materials & Interfaces;2024-02-09

3. Bisphosphonate conjugation enhances the bone-specificity of NELL-1-based systemic therapy for spaceflight-induced bone loss in mice;npj Microgravity;2023-09-18

4. Genetic and pharmacologic suppression of PPARγ enhances NELL-1-stimulated bone regeneration;Biomaterials;2022-08

5. Therapeutic application of 3B-PEG injectable hydrogel/Nell-1 composite system to temporomandibular joint osteoarthritis;Biomedical Materials;2021-11-19